The inhibition pathway in treated breast cancer cells with the combination of Ad-VT and paclitaxel was analyzed using caspase activity analysis, JC-1 staining, Hoechst staining and Annexin V-FITC/PI flow assays. This evidence concerns the gene ANXA5 and breast cancer.